First decide whether this is an emergency
A return to substance use can range from a brief episode to sustained use and does not erase earlier recovery gains. It is a signal to reassess risk, treatment intensity, medication, triggers, support, and practical barriers rather than a reason to delay help until the situation becomes worse. Check responsiveness and breathing, ask what may have been used, and look for signs that require 911. Do not spend time debating whether the episode counts as a relapse while overdose or severe withdrawal is possible.
Return to use calls for treatment review
NIDA describes addiction as a chronic, treatable condition in which return to use can occur and indicates that treatment should be reviewed or modified when it does. Continued engagement, evidence-based medication, behavioral care, and recovery support can reduce harm and help a person regain stability. The care team should examine medication, level of care, triggers, access, mental health, housing, and missed appointments. Repeating the unchanged plan without reassessment can leave the same barriers in place.
Ask what happened without conducting an interrogation
Begin by asking what was used, when, how much, whether substances were mixed, and whether the person is awake, breathing, and medically stable. After immediate risk is addressed, contact the treatment team, restart prescribed care under guidance, review what happened, and arrange a concrete appointment. Short, direct questions about substance, amount, timing, mixing, and current symptoms support immediate decisions. A detailed review of triggers and choices can wait until the person is medically stable and able to participate.
Reduced tolerance changes overdose risk
Tolerance may fall during abstinence, increasing overdose risk if previous amounts are used again. Call 911 for unresponsiveness, slowed breathing, a seizure, chest pain, severe agitation, suicidal behavior, or confusion, and give naloxone whenever opioid exposure is possible. A dose used before a period of abstinence may be more dangerous afterward. Naloxone, avoiding use alone, and rapid connection to care are important even when opioids were not expected in the product.
A useful program keeps the door open
Ask whether the current program can provide rapid medication access, higher intensity, medical or psychiatric care, and practical support without punitive discharge. The plan should respond to the substance and cause of risk instead of automatically sending everyone to the same residential setting. Ask whether renewed use leads to clinical reassessment or automatic discharge. The program should be able to increase support, restart appropriate medication, or arrange transfer without using shame as a treatment strategy.
Write the re-entry steps before another episode
Replace secrecy and blame with a short written response plan covering naloxone, safe contacts, medication, transportation, high-risk places, and the next appointment. Family members should also maintain their boundaries and seek support rather than taking sole responsibility for monitoring another adult. List the treatment number, pharmacy, transportation, naloxone location, supportive contacts, and emergency signs. A short plan is more usable under stress than instructions scattered across messages and discharge papers.
How family members can help without taking over
Offer transport, help make a call, or stay present during an assessment if the person agrees and safety allows. Keep established limits around money, driving, children, and violence. Do not become the sole monitor of breathing, medication, or abstinence when professional care is needed. Family support is more sustainable when relatives also have their own counseling, peer support, or respite.